TCL Archive European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results June 5, 1987
TCL Archive First Round Of Cooperative Group Mergers Falls Short Of NCI’s Stated Goal February 4, 2011
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA. October 28, 2005
TCL Archive Rall Says NTP Must Have New Positions To Spend Extra $23 Million On Testing More Chemicals September 7, 1979
